2 sources checked · 2 source groups included · 1h ago
Still Watching
University of Cincinnati Cancer Center helps develop landmark pancreatic cancer drug
NPR and WLWT Cincinnati (Hearst) describe the same event in different terms.
1 Left1 Center0 Right
Still watching.Optics is waiting for a cleaner match before calling the split.
STILL WATCHING
As of August 27, 2026 at 6:54 AM, this is how Optics News reads the wording differences in this story.
What happenedThe University of Cincinnati Cancer Center is celebrating the role it played in developing a new drug used to treat pancreatic cancer.
The headline splitThe left frames it as "FDA approves landmark pancreatic cancer drug that's shown to improve survival". The center frames it as "University of Cincinnati Cancer Center helps develop landmark pancreatic cancer drug".
Match confidenceDeveloping. The source map is still developing. Keep watching for more sources to join.
Same-event confidenceDeveloping
Not enough sources yet to confirm this is the same specific event.
Framing confidenceHidden
Wording-gap score hidden — source map is too narrow to read confidently.
WHAT EACH SIDE EMPHASIZED
Left / center-leftFDA approves landmark pancreatic cancer drug that's shown to improve survival
NPR · Center-left · News report
CenterUniversity of Cincinnati Cancer Center helps develop landmark pancreatic cancer drug
WLWT Cincinnati (Hearst) · Center · News report
Right / center-rightNo matching source in this bucket yet.
FDA approves landmark pancreatic cancer drug that's shown to improve survival
U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer, by blocking a protein that fuels tumor growth i...
